Relative levels of let‑7a, miR‑17, miR‑27b, miR‑125a, miR‑125b and miR‑206 as potential molecular markers to evaluate grade, receptor status and molecular type in breast cancer

作者: TOMASZ P. LEHMANN , KONSTANTY KORSKI , ROBERT GRYCZKA , MATHEW IBBS , ANNA THIELEMAN

DOI: 10.3892/MMR.2015.4002

关键词:

摘要: MicroRNAs (miRNAs/miRs) are a class of short, single‑stranded nucleic acids, which have been investigated as potential molecular markers for various types cancer. The gold‑standard and most sensitive method comparing miRNA levels in cancer tissues is reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR). This technique uses stably expressed genes normalisation. aim the present study was to improve this model analysis context RT‑qPCR results. A total six known miRNAs (let‑7a, miR‑17, miR‑27b, miR‑125a, miR‑125b miR‑206), RNU6B RNA five mRNAs [erb‑b2 receptor tyrosine kinase 2 (ERBB2), hydroxymethylbilane synthase (RNA) II (DNA directed) polypeptide A] were analysed pair‑wise, order determine biomarker pairs best correlated with histological groups 27 breast samples. lowest P‑values highest area under curve values receiver operating characteristic used select optimum ratios discrimination among groups. Among 21 pairs, miR‑17/miR‑27b miR‑125a/RNU6B discriminated three samples different tumour grades (G classification). miR‑125b/miR‑206 two sizes (pT), let‑7a/RNU6B lymph node status (pN), let‑7a/miR‑125b negative positive oestrogen progesterone status. No pair found discriminate well between either or human epidermal growth factor (HER2) However, one miRNA/mRNA pair, miR‑125a/ERBB2, HER2‑negative from HER2‑positive grouped by immunohistological methods into classes: Luminal, HER2 basal (L, H B, respectively). In discern L selected: miR‑125a/miR‑125b miR‑125a/miR‑206. conclusion, pair‑wise data may be reasonable alternative standard using reference genes, such RNA, increase classification power biomarkers diagnostics.

参考文章(49)
Clemens L. Bockmeyer, Matthias Christgen, Mirco Müller, Sebastian Fischer, Philipp Ahrens, Florian Länger, Hans Kreipe, Ulrich Lehmann, MicroRNA profiles of healthy basal and luminal mammary epithelial cells are distinct and reflected in different breast cancer subtypes Breast Cancer Research and Treatment. ,vol. 130, pp. 735- 745 ,(2011) , 10.1007/S10549-010-1303-3
Danila Serpico, Leonardo Molino, Serena Di Cosimo, microRNAs in breast cancer development and treatment. Cancer Treatment Reviews. ,vol. 40, pp. 595- 604 ,(2014) , 10.1016/J.CTRV.2013.11.002
N Falkenberg, N Anastasov, K Rappl, H Braselmann, G Auer, A Walch, M Huber, I Höfig, M Schmitt, H Höfler, M J Atkinson, M Aubele, MiR-221/-222 differentiate prognostic groups in advanced breast cancers and influence cell invasion British Journal of Cancer. ,vol. 109, pp. 2714- 2723 ,(2013) , 10.1038/BJC.2013.625
Gilson Costa dos Santos Jr, Andrea Carla de Souza Goes, Humberto de Vitto, Carla Cristina Moreira, Elizabeth Avvad, Franklin David Rumjanek, Claudia Vitoria de Moura Gallo, Genomic instability at the 13q31 locus and somatic mtDNA mutation in the D-loop site correlate with tumor aggressiveness in sporadic Brazilian breast cancer cases Clinics. ,vol. 67, pp. 1181- 1190 ,(2012) , 10.6061/CLINICS/2012(10)10
Pedro F Escobar, Rebecca J Patrick, Lisa A Rybicki, David E Weng, Joseph P Crowe, The 2003 Revised TNM Staging System for Breast Cancer: Results of Stage Re-classification on Survival and Future Comparisons among Stage Groups Annals of Surgical Oncology. ,vol. 14, pp. 143- 147 ,(2006) , 10.1245/S10434-006-9147-0
Guisheng Song, Yuxia Zhang, Li Wang, MicroRNA-206 Targets notch3, Activates Apoptosis, and Inhibits Tumor Cell Migration and Focus Formation Journal of Biological Chemistry. ,vol. 284, pp. 31921- 31927 ,(2009) , 10.1074/JBC.M109.046862
Bjørn A Nexø, Ulla Vogel, Anja Olsen, Mette Nyegaard, Zuzanna Bukowy, Eszter Rockenbauer, Xiuqing Zhang, Cemile Koca, Mette Mains, Bettina Hansen, Anne Hedemand, Anette Kjeldgaard, Magdalena J Laska, Ole Raaschou-Nielsen, Søren Cold, Kim Overvad, Anne Tjønneland, Lars Bolund, Anders D Børglum, None, Linkage disequilibrium mapping of a breast cancer susceptibility locus near RAI/PPP1R13L/iASPP BMC Medical Genetics. ,vol. 9, pp. 56- 56 ,(2008) , 10.1186/1471-2350-9-56
Yuki Tsuchiya, Miki Nakajima, Shingo Takagi, Takao Taniya, Tsuyoshi Yokoi, MicroRNA Regulates the Expression of Human Cytochrome P450 1B1 Cancer Research. ,vol. 66, pp. 9090- 9098 ,(2006) , 10.1158/0008-5472.CAN-06-1403